28 related articles for article (PubMed ID: 9890179)
1. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.
Hirano K; Minamoto T
Cancer Detect Prev; 2000; 24(4):343-55. PubMed ID: 11059565
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C
Clin Cancer Res; 1999 May; 5(5):977-83. PubMed ID: 10353729
[TBL] [Abstract][Full Text] [Related]
5. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
[TBL] [Abstract][Full Text] [Related]
6. Re: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Rubin MA
J Natl Cancer Inst; 1999 Jan; 91(1):91. PubMed ID: 9890179
[No Abstract] [Full Text] [Related]
7. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in chronic lymphocytic leukaemia.
Binet JL
Haematologica; 1999 Jun; 84 Suppl EHA-4():96-7. PubMed ID: 10907482
[No Abstract] [Full Text] [Related]
9. Stem cell features of benign and malignant prostate epithelial cells.
De Marzo AM; Nelson WG; Meeker AK; Coffey DS
J Urol; 1998 Dec; 160(6 Pt 2):2381-92. PubMed ID: 9817389
[TBL] [Abstract][Full Text] [Related]
10. Current and proposed biologic markers in prostate cancer: 1994.
Bostwick DG; Qian J
J Cell Biochem Suppl; 1994; 19():197-201. PubMed ID: 7823592
[No Abstract] [Full Text] [Related]
11. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.
De Marzo AM; Coffey DS; Nelson WG
Urology; 1999 Mar; 53(3 Suppl 3a):29-39; discussion 39-42. PubMed ID: 10094098
[TBL] [Abstract][Full Text] [Related]
12. Morphologic and molecular prognostic markers in prostate cancer.
Ross JS; Sheehan CE; Dolen EM; Kallakury BV
Adv Anat Pathol; 2002 Mar; 9(2):115-28. PubMed ID: 11917165
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]